Artificial Intelligence (AI) is driving significant economic, technological change including education, personal and professional learning. However, high school business education content remains largely outdated, rigid and static making the learning experience unengaged and stale creating a critical gap between the need for the business education and the delivery of the learning. This gap is especially detrimental given modern business’s reliance on AI for data analysis and decision-making, compounded by the persistent lack of financial literacy instruction in these traditional business education trainings. Many students graduate without a foundational understanding of key financial concepts such as mortgages, interest rates, loans, or credit management, increasing their vulnerability to financial mismanagement in adulthood. This paper proposes integrating AI’s transformative potential into high school business education with specific examples. It argues that AI-powered tools, including personalized learning platforms, adaptive modules, immersive business simulations, and gamification strategies, can bridge this divide by enhancing financial literacy and fostering technological proficiency. By incorporating these AI-based techniques, educators can transform traditional curricula into engaging and interactive learning experiences that better prepare students for financial independence, entrepreneurship, and success in modern business environments. In an era when AI is reshaping industries, it is imperative that high school business education evolves to equip students with the financial and technological skills necessary for the future workforce. This paper also discusses the challenges of incorporating AI, such as inadequate teacher training, rigid curricula, and limited funding, and proposes viable solutions.

The emergence of novel biomedical developments has brought new challenges regarding patient and informational privacy concerns previously unseen in the medical field. Healthcare’s computerization and digitization, originating in the 1960s, have evolved at an exponential rate. However, this rapid advancement has often neglected proper cybersecurity protocols, treating them as an afterthought. Sixty years later, data leaks, security breaches, and cyberattacks are commonplace, putting sensitive patient information at risk more than ever before, with millions already affected by these attacks. Thus, an evaluation of such threats provides insight into the sustainability of the aforementioned novel biomedical developments in the industry. Through a literature review, this sustainability can be determined, revealing varying levels of concern regarding the need for cybersecurity implementations and innovations to achieve real application. Utilizing real-world case studies, reports on prior online leaks, and data on hospital cybersecurity, this analysis highlights the multitude of common vulnerabilities found throughout bioinformatics and healthcare while underscoring the potential dangers if these vulnerabilities were to be exploited. Ultimately, this article intends to issue a call to action to protect patient integrity and uphold HIPAA as medicine and technology continue to adapt alongside each other.

Three-dimensional (3D) bioprinting represents one of the most developing fields of biomedical engineering and regenerative medicine. 3D bioprinting integrates the use of additive manufacturing used to create devices with the biological understanding of human and animal physiology to create complex tissues and organs from scratch using various bioinks and biological scaffolds. The engineering perspective comes in 3D printing through the lens of biomechanics to implement the material, innovative bioink properties, scaffold designs, and printing techniques for precise layering. However, scientific persuasion must still overcome issues with cell health post printing, construction vascularization & functionality, and generated tissue durability. Through the lens of a medical approach, 3D printing holds a great deal of value for regenerative medicine such as skin grafts, craniofacial surgery, orthopedic procedures, dental solutions, and organs for transplant. There are some clinical limitations which can be overseen through regulatory concerns, biocompatibility challenges, and ethical issues . Finally, from a business standpoint, this market has significant potential. 3D bioprinting affects new market generation from pharmaceutical testing in 3D bioprinted lungs and tumor constructs to expansion in regenerative patches with future goals for anatomical perfection. Bioprinting is already commercially effective in small markets, but larger endeavors are limited due to scalable and reproducible inadequacies in research materials along with high research costs. The market for this is mostly in research and development (R&D) stages and is expected to gradually increase in demand over time in effective pharmaceutical testing and academic solutions, but no solid predictions for widespread clinical applicability for decades. This paper assesses 3D organ bioprinting through the lenses of engineering, medicine, and business to determine the realities of viability, practicality, and ethics in new interdisciplinary integration. Without a multidisciplinary approach gained through an understanding of all three perspectives, 3D bioprinting cannot achieve its full potential to change the world.